UNSPSC 41141622: Leucine aminopeptidase

In this classification, this entry connotes a Leucine aminopeptidase enzyme that is used in clinical chemistry testing.

UNSPSC 41141622 Leucine aminopeptidase is a Commodity code that does not align with recent state and local procurement activity in the source material. The code nominally refers to a specific enzyme product, but the eleven recent solicitations posted between February and June 2026 consistently procure laboratory reagents, consumables, and instruments for genomic sequencing, pathogen detection, and diagnostic testing — none of which involve leucine aminopeptidase or enzyme products. The Texas Health and Human Services Commission dominates the activity, repeatedly soliciting next-generation sequencing kits (Illumina Viral Surveillance Panel, Clear Dx reagent bundles), solid-phase extraction disks (Atlantic ReadyDisk HC-C18), culture media for foodborne pathogen identification, gas chromatography standards for drinking water analysis, and sequencing instruments. The Mississippi State Department of Health issued sole-source procurements for Clear Labs and Illumina sequencing reagents; the University of Texas Health Science Center at San Antonio posted an RFP for a comprehensive biotech research and clinical diagnostics catalog; the State of California sought MyCodeDR mycobacterial reagents and Cerilliant spiking solutions; and the City of Philadelphia issued a micro-purchase for extraction columns. None of these solicitations reference leucine aminopeptidase or align with the enzyme-product scope the code nominally describes.

The geographic spread includes Texas (five recent procurements), Mississippi (two), California (two), and Pennsylvania (one), with the bulk of activity concentrated in Texas public health laboratory operations. The most recent solicitations include the Texas HHSC IFB HHS0017272 for consumable respiratory pathogen detection kits posted June 25, 2026 with a May 19, 2026 response date, the Texas HHSC IFB HHS0017132 for culture media posted June 2, 2026 with a June 2, 2026 response date, and the University of Texas Health Science Center RFP 745-26-P19 for a biotech research and clinical diagnostics catalog posted May 7, 2026 with a June 4, 2026 response date. The code shows no genuine activity for leucine aminopeptidase procurement and appears to have been incorrectly assigned to these genomic and diagnostic laboratory solicitations.